J065--Bayer Medrad Injector Preventive Maintenance Service

specified for receipt of Offers E. IMPORTANT: is extended, (a) By completing Items 8 and 15, and returning __________ copies of the amendment; (b) By acknowledging receipt of this amendment on each copy of the offer submitted; or (c) By separate letter or electronic communication which includes a reference to the solicitation and amendment numbers. FAILURE OF YOUR ACKNOWLEDGMENT TO BE RECEIVED AT THE PLACE DESIGNATED FOR THE RECEIPT OF OFFERS PRIOR TO THE HOUR AND DATE SPECIFIED MAY is not extended. 12. ACCOUNTING AND APPROPRIATION DATA (REV. 11/2016) is required to sign this document and return ___________ copies to the issuing office. is not, A. THIS CHANGE ORDER IS ISSUED PURSUANT TO: (Specify authority) THE CHANGES SET FORTH IN ITEM 14 ARE MADE IN THE CONTRACT ORDER NO. IN ITEM 10A. 15C. DATE SIGNED B. THE ABOVE NUMBERED CONTRACT/ORDER IS MODIFIED TO REFLECT THE ADMINISTRATIVE CHANGES SET FORTH IN ITEM 14, PURSUANT TO THE AUTHORITY OF FAR 43.103(b). RESULT IN REJECTION OF YOUR OFFER. If by virtue of this amendment you desire to change an offer already submitted, such change may be made by letter or electronic communication, provided each letter or electronic communication makes reference to the solicitation and this amendment, and is received prior to the opening hour and date specified. C. THIS SUPPLEMENTAL AGREEMENT IS ENTERED INTO PURSUANT TO AUTHORITY OF: D. OTHER Contractor 16C. DATE SIGNED 14. DESCRIPTION OF AMENDMENT/MODIFICATION 16B. UNITED STATES OF AMERICA Except as provided herein, all terms and conditions of the document referenced in Item 9A or 10A, as heretofore changed, remains unchanged and in full force and effect. 15A. NAME AND TITLE OF SIGNER 16A. NAME AND TITLE OF CONTRACTING OFFICER 15B. CONTRACTOR/OFFEROR STANDARD FORM 30 PREVIOUS EDITION NOT USABLE Prescribed by GSA - FAR (48 CFR) 53.243 (Type or print) (Type or print) (Organized by UCF section headings, including solicitation/contract subject matter where feasible.) (Number, street, county, State and ZIP Code) (If other than Item 6) (Specify type of modification and authority) (such as changes in paying office, appropriation date, etc.) (If required) (SEE ITEM 11) (SEE ITEM 13) (X) CHECK ONE 13. THIS ITEM APPLIES ONLY TO MODIFICATIONS OF CONTRACTS/ORDERS, IT MODIFIES THE CONTRACT/ORDER NO. AS DESCRIBED IN ITEM 14. 11. THIS ITEM ONLY APPLIES TO AMENDMENTS OF SOLICITATIONS AMENDMENT OF SOLICITATION/MODIFICATION OF CONTRACT (Signature of person authorized to sign) (Signature of Contracting Officer) 1 2 0001 08-31-2026 619-27-1-244-0024 None 508A DEPARTMENT OF VETERANS AFFAIRS VETERANS HEALTH ADMINISTRATION Network Contracting Office (NCO) 7 2957 CLAIRMONT ROAD NE, Suite 1200 Atlanta GA 30329 508A DEPARTMENT OF VETERANS AFFAIRS VETERANS HEALTH ADMINISTRATION Network Contracting Office (NCO) 7 2957 CLAIRMONT ROAD NE, Suite 1200 Atlanta GA 30329 To all Offerors/Bidders 36C24727Q0009 X X X ** HOUR & DATE for Receipt of Offers is EXTENDED to: 09-04-2026 12PM EDT 619-3670160-244-825500-2520 0100555Yl x 1 The purpose of this amendment is to: 1. The question period for this solicitation is hereby closed. No additional vendor questions will be accepted. 2. The attached Vendor Questions and Answers are hereby incorporated into and made part of the solicitation. 3. The Instructions to Offerors and Evaluation Factors are hereby revised. 4. The revised Statement of Work (SOW) is hereby incorporated into and made part of the solicitation. 5.The due date for receipt of quotations is extended from September 2, 2026, at 12:00 PM EST to September 4, 2026 12PM EST. All other terms and conditions remain unchanged. Jessica Cummings Contracting Officer Page 20 of 20 Bayer MEDRAD Injector PM/Repair Solicitation: 36C24727Q0009 Questions and Answers: 1. Question: The solicitation identifies OEM Authorization and Support as an evaluation factor and states that documentation may demonstrate the ability to obtain required proprietary services through Bayer HealthCare LLC or another Bayer-authorized arrangement. Does a documented teaming or subcontracting arrangement with a firm that has the necessary Bayer authorization/support satisfy this requirement, or must the Offeror itself hold direct Bayer/MEDRAD authorization? The Offeror is not required to independently hold direct Bayer/MEDRAD authorization. However, the Offeror shall provide documentation demonstrating its ability to obtain the required Bayer OEM-authorized support necessary to perform the requirements of the SOW. If the Offeror proposes to use a teaming, subcontracting, or other formal arrangement, the Offeror shall provide documentation demonstrating the relationship or arrangement and that the proposed firm possesses the necessary Bayer authorization and capabilities to provide the required OEM support. 2. Question: The addendum mentions applicable SEWP ordering requirements. Please confirm whether this language applies to this requirement or is leftover language from a different template, since this does not appear to be a SEWP procurement. The reference to applicable SEWP ordering requirements was included in error and is not applicable to this solicitation. The reference is removed through this amendment. All other applicable registration and certification requirements of the solicitation remain unchanged. 3. Question: Section B.1 (page 5) states that payment is quarterly in arrears, as does the Price/Cost Schedule; however, Section B.1.15 (page 14) states that payment is semi-annually in arrears. Are the correct payment terms quarterly in arrears? Yes. The correct payment terms are quarterly in arrears. The SOW has been revised to reflect the correct payment frequency. ADDENDUM to FAR 52.212-1 INSTRUCTIONS TO OFFERORS COMMERCIAL PRODUCTS AND COMMERCIAL SERVICES Provisions that are incorporated by reference (by Citation Number, Title, and Date), have the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. The following provisions are incorporated into 52.212-1 as an addendum to this solicitation: The Offeror shall submit a complete quotation demonstrating its ability to meet all requirements of the Statement of Work (SOW). The quotation shall include, at a minimum, the following: 1. Technical Capability The Offeror shall provide sufficient information demonstrating its capability to perform all required preventive maintenance and repair services for the Bayer MEDRAD injector systems identified in the SOW. The Offeror shall demonstrate its ability to provide all required preventive maintenance, calibration, diagnostics, software and cybersecurity updates, corrective maintenance, technical support, replacement parts, and other services required by the SOW. 2. OEM Authorization and Support The Offeror shall provide documentation demonstrating its ability to obtain and provide the required Bayer OEM support necessary to perform the requirements of the SOW. The documentation shall demonstrate access to the applicable proprietary software, diagnostic and calibration tools, software and cybersecurity updates, technical support, and OEM replacement parts necessary to maintain the equipment in accordance with manufacturer specifications. The Offeror is not required to independently hold direct Bayer/MEDRAD authorization. If the Offeror proposes to utilize a teaming, subcontr